# Safety Study of GMDTC Injection in Participants With Excessive Cadmium

> **NCT06199349** · PHASE1 · COMPLETED · sponsor: **Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd.** · enrollment: 30 (actual)

## Conditions studied

- Cadmium Exceeds the Standard

## Interventions

- **DRUG:** GMDTC for injection
- **OTHER:** Normal saline

## Key facts

- **NCT ID:** NCT06199349
- **Lead sponsor:** Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-08
- **Primary completion:** 2024-10-21
- **Final completion:** 2024-12-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06199349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06199349, "Safety Study of GMDTC Injection in Participants With Excessive Cadmium". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06199349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*